Alison Blaus

Alison Blaus is currently the Vice President and Head of Regulatory Affairs at Dispatch Bio, where they serve as the Global Regulatory Lead for late-stage and early-stage CAR T therapies targeting B-cell malignancies. Previously, Blaus held various regulatory roles at Gilead Sciences, Pfizer, Kite Pharma, Bristol Myers Squibb, and the FDA, where they developed regulatory strategies and managed complex submissions. Alison earned a Bachelor of Science in Neuroscience from the University of Delaware.